Cargando…

A 5-Gene Prognostic Combination for Predicting Survival of Patients with Gastric Cancer

BACKGROUND: The aim of the study was to identify a multigene prognostic factor in patients with gastric cancer (GC). MATERIAL/METHODS: Random survival forest (RSF) was performed to screen survival-related genes and develop a multigene combination based on the cumulative hazard function of each GC pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Liang, Wang, Xiao-Yan, He, Xiao-Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713029/
https://www.ncbi.nlm.nih.gov/pubmed/31422414
http://dx.doi.org/10.12659/MSM.914815
_version_ 1783446800325148672
author Song, Liang
Wang, Xiao-Yan
He, Xiao-Feng
author_facet Song, Liang
Wang, Xiao-Yan
He, Xiao-Feng
author_sort Song, Liang
collection PubMed
description BACKGROUND: The aim of the study was to identify a multigene prognostic factor in patients with gastric cancer (GC). MATERIAL/METHODS: Random survival forest (RSF) was performed to screen survival-related genes and develop a multigene combination based on the cumulative hazard function of each GC patient in TCGA-STAD and GSE15459. Kaplan-Meier curve and univariate and multivariable Cox proportional hazards regression model were applied to evaluate the prognostic performance of the 5-gene combination. C-index was used to compare the prognostic performance of the 5-gene combination and another 9-gene signature in GC. Gene set enrichment analysis (GSEA) was conducted. RESULTS: We obtained 19 survival-related genes through univariate Cox proportional hazards analysis in the training set, 5 of which were identified and were used to develop a 5-gene combination through RSF. Patients in the 5-gene combination low-risk group had better overall survival (OS) than those in the 5-gene combination high-risk group, and the 5-gene combination was demonstrated to be an independent prognostic factor in patients with GC. The 5-gene combination outperformed the 9-gene signature in predicting the OS of GC patients, and it might affect the prognosis of GC patients through E2F signaling, MYC signaling, and G2M checkpoint. CONCLUSIONS: We introduce a 5-gene combination that can predict the survival of GC patients and might be an independent prognostic factor in GC.
format Online
Article
Text
id pubmed-6713029
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher International Scientific Literature, Inc.
record_format MEDLINE/PubMed
spelling pubmed-67130292019-11-18 A 5-Gene Prognostic Combination for Predicting Survival of Patients with Gastric Cancer Song, Liang Wang, Xiao-Yan He, Xiao-Feng Med Sci Monit Lab/In Vitro Research BACKGROUND: The aim of the study was to identify a multigene prognostic factor in patients with gastric cancer (GC). MATERIAL/METHODS: Random survival forest (RSF) was performed to screen survival-related genes and develop a multigene combination based on the cumulative hazard function of each GC patient in TCGA-STAD and GSE15459. Kaplan-Meier curve and univariate and multivariable Cox proportional hazards regression model were applied to evaluate the prognostic performance of the 5-gene combination. C-index was used to compare the prognostic performance of the 5-gene combination and another 9-gene signature in GC. Gene set enrichment analysis (GSEA) was conducted. RESULTS: We obtained 19 survival-related genes through univariate Cox proportional hazards analysis in the training set, 5 of which were identified and were used to develop a 5-gene combination through RSF. Patients in the 5-gene combination low-risk group had better overall survival (OS) than those in the 5-gene combination high-risk group, and the 5-gene combination was demonstrated to be an independent prognostic factor in patients with GC. The 5-gene combination outperformed the 9-gene signature in predicting the OS of GC patients, and it might affect the prognosis of GC patients through E2F signaling, MYC signaling, and G2M checkpoint. CONCLUSIONS: We introduce a 5-gene combination that can predict the survival of GC patients and might be an independent prognostic factor in GC. International Scientific Literature, Inc. 2019-08-18 /pmc/articles/PMC6713029/ /pubmed/31422414 http://dx.doi.org/10.12659/MSM.914815 Text en © Med Sci Monit, 2019 This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) )
spellingShingle Lab/In Vitro Research
Song, Liang
Wang, Xiao-Yan
He, Xiao-Feng
A 5-Gene Prognostic Combination for Predicting Survival of Patients with Gastric Cancer
title A 5-Gene Prognostic Combination for Predicting Survival of Patients with Gastric Cancer
title_full A 5-Gene Prognostic Combination for Predicting Survival of Patients with Gastric Cancer
title_fullStr A 5-Gene Prognostic Combination for Predicting Survival of Patients with Gastric Cancer
title_full_unstemmed A 5-Gene Prognostic Combination for Predicting Survival of Patients with Gastric Cancer
title_short A 5-Gene Prognostic Combination for Predicting Survival of Patients with Gastric Cancer
title_sort 5-gene prognostic combination for predicting survival of patients with gastric cancer
topic Lab/In Vitro Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713029/
https://www.ncbi.nlm.nih.gov/pubmed/31422414
http://dx.doi.org/10.12659/MSM.914815
work_keys_str_mv AT songliang a5geneprognosticcombinationforpredictingsurvivalofpatientswithgastriccancer
AT wangxiaoyan a5geneprognosticcombinationforpredictingsurvivalofpatientswithgastriccancer
AT hexiaofeng a5geneprognosticcombinationforpredictingsurvivalofpatientswithgastriccancer
AT songliang 5geneprognosticcombinationforpredictingsurvivalofpatientswithgastriccancer
AT wangxiaoyan 5geneprognosticcombinationforpredictingsurvivalofpatientswithgastriccancer
AT hexiaofeng 5geneprognosticcombinationforpredictingsurvivalofpatientswithgastriccancer